Abstract
Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Drug Delivery Letters
Title:Nanosponge: A Novel Carrier for Drug Delivery
Volume: 3 Issue: 3
Author(s): Rehana Ansari, Rachna Maheshwari, Shikha Jain, Suresh C. Mahajan and Vikas Jain
Affiliation:
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Abstract: Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Export Options
About this article
Cite this article as:
Ansari Rehana, Maheshwari Rachna, Jain Shikha, C. Mahajan Suresh and Jain Vikas, Nanosponge: A Novel Carrier for Drug Delivery, Drug Delivery Letters 2013; 3 (3) . https://dx.doi.org/10.2174/22103031113039990004
DOI https://dx.doi.org/10.2174/22103031113039990004 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
Current Medicinal Chemistry MicroRNAs as Cancer Biomarkers
MicroRNA Vitamin Bs, One Carbon Metabolism and Prostate Cancer
Mini-Reviews in Medicinal Chemistry Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies
Current Drug Therapy Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Current Neuropharmacology Meet Our Editorial Board Member:
Current Drug Targets Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry In Silico and Biochemical Analyses Identify Quinone Reductase 2 as a Target of Piceatannol
Current Medicinal Chemistry Sumoylation as an Emerging Target in Therapeutics against Cancer
Current Pharmaceutical Design Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers
Current Medicinal Chemistry Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Virtual Screening of Natural Products Database
Mini-Reviews in Medicinal Chemistry Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication
Anti-Cancer Agents in Medicinal Chemistry Your Father and Grandfather’s Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia
Current Genomics Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Potential Therapeutic Agents from the Red Sea Organisms
Medicinal Chemistry Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
Current Pharmaceutical Design The Vitamin D/CYP24A1 Story in Cancer
Anti-Cancer Agents in Medicinal Chemistry